These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25664853)

  • 21. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
    Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
    PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles for MSI2 and PROX1 in hematopoietic stem cell activity.
    Hope KJ; Sauvageau G
    Curr Opin Hematol; 2011 Jul; 18(4):203-7. PubMed ID: 21577104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
    Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
    Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the RNA m
    Paris J; Morgan M; Campos J; Spencer GJ; Shmakova A; Ivanova I; Mapperley C; Lawson H; Wotherspoon DA; Sepulveda C; Vukovic M; Allen L; Sarapuu A; Tavosanis A; Guitart AV; Villacreces A; Much C; Choe J; Azar A; van de Lagemaat LN; Vernimmen D; Nehme A; Mazurier F; Somervaille TCP; Gregory RI; O'Carroll D; Kranc KR
    Cell Stem Cell; 2019 Jul; 25(1):137-148.e6. PubMed ID: 31031138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of musashi-2 gene in leukemia stem cells from acute myeloid leukemia patients].
    Ye AF; Han YX; Zhang SH; Li HY; Chen CQ; Wu JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1235-8. PubMed ID: 25338564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of Musashi‑2 by the small compound largazole exerts inhibitory effects on malignant cells.
    Wang M; Sun XY; Zhou YC; Zhang KJ; Lu YZ; Liu J; Huang YC; Wang GZ; Jiang S; Zhou GB
    Int J Oncol; 2020 May; 56(5):1274-1283. PubMed ID: 32319553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
    Somervaille TC; Cleary ML
    Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia.
    Minuesa G; Albanese SK; Xie W; Kazansky Y; Worroll D; Chow A; Schurer A; Park SM; Rotsides CZ; Taggart J; Rizzi A; Naden LN; Chou T; Gourkanti S; Cappel D; Passarelli MC; Fairchild L; Adura C; Glickman JF; Schulman J; Famulare C; Patel M; Eibl JK; Ross GM; Bhattacharya S; Tan DS; Leslie CS; Beuming T; Patel DJ; Goldgur Y; Chodera JD; Kharas MG
    Nat Commun; 2019 Jun; 10(1):2691. PubMed ID: 31217428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice.
    Kong CT; Sham MH; So CW; Cheah KS; Chen SJ; Chan LC
    Leukemia; 2006 Oct; 20(10):1829-39. PubMed ID: 16888613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.
    Nguyen CH; Bauer K; Hackl H; Schlerka A; Koller E; Hladik A; Stoiber D; Zuber J; Staber PB; Hoelbl-Kovacic A; Purton LE; Grebien F; Wieser R
    Cell Death Dis; 2019 Dec; 10(12):944. PubMed ID: 31822659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PAF1c Subunit CDC73 Is Required for Mouse Hematopoietic Stem Cell Maintenance but Displays Leukemia-Specific Gene Regulation.
    Saha N; Ropa J; Chen L; Hu H; Mysliwski M; Friedman A; Maillard I; Muntean AG
    Stem Cell Reports; 2019 May; 12(5):1069-1083. PubMed ID: 31031188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.
    Holm F; Hellqvist E; Mason CN; Ali SA; Delos-Santos N; Barrett CL; Chun HJ; Minden MD; Moore RA; Marra MA; Runza V; Frazer KA; Sadarangani A; Jamieson CH
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15444-9. PubMed ID: 26621726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
    Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
    J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia.
    Kaeda J; Ringel F; Oberender C; Mills K; Quintarelli C; Pane F; Koschmieder S; Slany R; Schwarzer R; Saglio G; Hemmati P; van Lessen A; Amini L; Gresse M; Vagge E; Burmeister T; Serra A; Carson A; Schwarz M; Westermann J; Jundt F; Dörken B; le Coutre P
    Leuk Lymphoma; 2015 Jul; 56(7):2105-13. PubMed ID: 25363400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.
    Liu Q; Chen L; Atkinson JM; Claxton DF; Wang HG
    Cell Death Dis; 2016 Sep; 7(9):e2361. PubMed ID: 27607576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Musashi2 is required for the self-renewal and pluripotency of embryonic stem cells.
    Wuebben EL; Mallanna SK; Cox JL; Rizzino A
    PLoS One; 2012; 7(4):e34827. PubMed ID: 22496868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia.
    Spinler K; Hamilton M; Bajaj J; Shima Y; Diaz E; Kritzik M; Reya T
    bioRxiv; 2023 Dec; ():. PubMed ID: 38234720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
    Chen L; Sun Y; Wang J; Jiang H; Muntean AG
    Oncotarget; 2016 May; 7(18):25208-23. PubMed ID: 27007052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.